Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rexall Sundown

This article was originally published in The Tan Sheet

Executive Summary

Completes acquisition of the Verona, Penn. manufacturing facility of Pennex Products, Rexall said Sept. 30 ("The Tan Sheet" Sept. 27, p. 11). Rexall will apparently keep the Pennex name; the firm has created a wholly owned subsidiary called Pennex Labs. Terms of the purchase were approved by U.S. Bankruptcy Court and include cash payments of $ 3 mil., the "assumption of certain liabilities approximating $ 275,000 and the assumption of debtor in possession financing provided" by Rexall. Rexall announced its intention to purchase Pennex on the day the company filed a Chapter 11 petition in U.S. Bankruptcy Court ("The Tan Sheet" Aug. 16, p. 19). Rexall said it expects Pennex to "return to profitability within 12 months".

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS081988

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel